Verona hits record high after Merck's $10 billion acquisition

Verona Pharma

09/07/2025 16:17

Updates

** U.S.-listed shares of lung therapy firm Verona Pharma VRNA.O I9SAy.F jump 20.7% to all-time high of $104.81

** Verona set of its best day in over 2 years, if gains hold

** Merck MRK.N will buy London-based Verona for about $10 billion

** Merck will pay $107 per American depository share for Verona

** Shares of Merck up 2.5% at $83.40

** The purchase price is a premium of about 23% to Verona ADS' last closing price

** The Financial Times first reported the deal on Wednesday

** Including session moves, Verona up 125.7%, Merck down 16.3% YTD

 (Reporting by Christy Santhosh, Siddhi Mahatole and Kamal Choudhury)

 ((Christy.Santhosh@thomsonreuters.com))